skip to content
Detailed Quote
5i Report
Rating
B+

Review of Stantec Inc

DEC 07, 2023 - STN is coming off a strong Q3 where earnings and revenue surpassed expectations while also delivering organic growth and margin improvement. Valuation looks good when considering shares are trading near a 52-week high and comparing to trailing multiples. Expectations for growth in revenue and EPS looks moderate for the next two years, while STN has a large backlog of business, providing comfort regarding the future of the business. Rating is maintained at a B+.

Download Report
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Hi Group please share your top 4 sectors c/w 3 stocks in each. (please rate the 3 in order of preferred order to add) also if you could suggest a good entry price (i intend to average in over the next 6 months presently no defense /manufacturing exposure also light on health care. I have 20% of my portfolio in cash. thanks
Read Answer Asked by Terence on March 27, 2025
Q: I sold half my holdings in BDT and ARE in December, in a TFSA, with a nice profit. Both are down quite a lot since then. I was planning to buy back to average down. Or take position in more stable stocks like STN or ATRL. How would you rank these 4 for new purchase? in a registered or regular account? Would any of these be more at risk with US politics ? I already own WSP and NOA. Thanks a lot.
Read Answer Asked by Denise on March 17, 2025
Insiders
Share Information
News and Media
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!